ANDA 86678, held by Mylan. Cyproheptadine Hydrochloride.
As of Nov 16, 2026, ANDA 86678 (Cyproheptadine Hydrochloride), held by Mylan, was first approved by FDA on Apr 23, 1979, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 23, 1979 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Cyproheptadine Hydrochloride4MG ยท tablet;oral | Cyproheptadine Hydrochloride | Discontinued |
| Dec 24, 1986 | Supplement 24Labeling | Approved | None posted |
| Apr 23, 1979 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters